Aion Therapeutic IncCanadian Securities Exchange:AIONView on OTC Pink - Current Information
- LAST PRICE0.0150
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0150/ 86
- Ask / Lots0.0200/ 1,969
- Open / Previous Close0.0150 / 0.0150
- Day Range
- 52 Week Range
- Volume35,500
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | AION |
|---|---|---|
| 01:04 ET | 35000 | 0.015 |
Nov 13, 2024
Aion Therapeutic Announces Revocation of MCTO, from 6:49PM ET on Wednesday Nov 13, 2024 by Dow Jones
6:49PM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aion Therapeutic Inc | 7.1M | -0.9x | --- |
Australis Capital Inc | 7.8M | -0.4x | --- |
Mountain Valley MD Holdings Inc | 9.9M | -1.3x | --- |
Nass Valley Gateway Ltd | 10.9M | -6.3x | --- |
Lobe Sciences Ltd | 3.4M | -0.6x | --- |
Genix Pharmaceuticals Corp | 2.4M | -0.6x | --- |
Company Information
Aion Therapeutic Inc. is a Canada-based company, which operates within the health and wellness sector with a diverse portfolio of intellectual property. The Company, through its subsidiary, AI Pharmaceuticals Jamaica Limited, is engaged in research, development and treatment, as well as new therapeutic formulation discovery using data mining and artificial intelligence (AI) techniques. The Company develops healing chemical compounds from medical cannabis in combination with chemical compounds from psychedelic and edible mushrooms to treat conditions, such as cancer, depression, post-traumatic stress disorder (PTSD) and others, as well as opioid and alcohol addiction. The Company is also engaged in offering a water filtration system that incorporates mechanical filtration, membrane filtration, adsorption, silver infection control, ion exchange, and chemical additions into a three-stage water purification solution designed to meet the needs of consumers, business, and industries.
Contact Information
- Headquarters
- 700 West Georgia Street, Suite 2200ONTARIO, ON, Canada V7Y 1K8
- Phone
- 604-558-4300
- Fax
- 778-480-6455
Executives
- Chief Executive Officer, Director
- Graham Simmonds
- Chief Financial Officer
- Rakesh Malhotra
- Director
- Stephen Barnhill
- Director
- Paul Crath
- Director
- Anthony Hall
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.1M |
|---|---|
Revenue (TTM) | $802.3K |
Shares Outstanding | 475.1M |
Aion Therapeutic Inc does not pay a dividend. | |
Beta | 0.49 |
EPS | $-0.02 |
Book Value | $-0.01 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 8.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -787.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
